Journals Library

HTA - 11/36/16

The Low Risk DCIS (ductal carcinoma in situ) Trial

Project title: The Low Risk DCIS (ductal carcinoma in situ) Trial

Call to action: 11/36 HTA Clinical Trials - November 2011 Board submission (May 2011 deadline)

Research type: Primary Research

Chief investigator: Dr Matthew WallisORCID

Contractor: University of Birmingham

Cost: £3,378,501.00

Co-investigators: Dr Daniel Rea, Dr Jeremy Thomas, Dr Matthew Wallis, Dr Sarah Bowden, Mrs Cassandra Brookes, Ms Maggie Wilcox, Professor Andrew Evans, Professor Andrew Hanby, Professor Dame Lesley Fallowfield, Professor David Dodwell, Professor John Bartlett, Professor Lucinda Billingham, Professor Malcolm Reed, Professor Sarah Pinder, Professor Tracy Roberts.

Started: April 2014 | Status: Research in progress

ISRCTN: 27544579

Links to project documentation

The links and documents below are related to this research and are added as and when they are produced over the life of the project. The information is provided by the researchers and some may have undergone varying editorial, production and publication models, which differ to NIHR Journals Library reports. Links are to both internal (NIHR) and external websites – the NIHR is not responsible for the content of external websites.

Background & Research Questions

Why the research is being done and what is being asked


How the research is being done


What the research found


What impact the research has had

If you would like to receive a notification when this project is updated, please submit your email address below.